Treatment-related hemophagocytic lymphohistiocytosis secondary to checkpoint inhibition with nivolumab plus ipilimumab

Affiliations

• ¹ Skin Cancer Center Hannover, Department of Dermatology and Allergy, Hannover Medical School, Carl Neuberg Str. 1, 30625 Hannover, Germany. Electronic address: Satzger.imke@mh-hannover.de.
• ² Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Carl Neuberg Str. 1, 30625 Hannover, Germany. Electronic address: Ivanyi.Philipp@mh-hannover.de.
• ³ Institute of Pathology, Hannover Medical School, Carl Neuberg Str. 1, 30625 Hannover, Germany. Electronic address: Laenger.Florian@mh-hannover.de.
• ⁴ Institute of Pathology, Hannover Medical School, Carl Neuberg Str. 1, 30625 Hannover, Germany. Electronic address: Kreipe.Hans@mh-hannover.de.
• ⁵ Skin Cancer Center Hannover, Department of Dermatology and Allergy, Hannover Medical School, Carl Neuberg Str. 1, 30625 Hannover, Germany.
• ⁶ Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Carl Neuberg Str. 1, 30625 Hannover, Germany. Electronic address: Beutel.Gernot@mh-hannover.de.
• ⁷ Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl Neuberg Str. 1, 30625 Hannover, Germany. Electronic address: Cornberg.Markus@mh-hannover.de.
• ⁸ Skin Cancer Center Hannover, Department of Dermatology and Allergy, Hannover Medical School, Carl Neuberg Str. 1, 30625 Hannover, Germany. Electronic address: Gutzmer.ralf@mh-hannover.de.